 |
|
Home
Home > FDA Approves New Inhaled Insulin
FDA Approves New Inhaled Insulin
Exubera may reduce the need for mealtime injections in some diabetics
Lehigh Valley, PA (August 25, 2006) -- Managing your blood sugar with mealtime insulin injections can be one of the most difficult parts of having diabetes. But your routine may get easier, thanks to a new inhaled insulin just approved by the Food and Drug Administration (FDA). Called Exubera, the product should be available by the summer.
Exubera is the only inhaled insulin approved by the FDA. It comes in a powder form that looks like a pill, but is loaded into a specially designed inhaler so it can be mixed with air, inhaled and absorbed through the lungs.
“Exubera is a fast-acting insulin that is used as a mealtime substitute for injected insulin, covering your insulin needs for one meal,” said pharmacist Michael Columbus, of Lehigh Valley Hospital and Health Network. “It is not a substitute for longer acting insulins, which will still need to be injected, and you still need to test your blood sugars.”
“Most people who need mealtime insulin should be able to use Exubera,” Columbus says. But it should not be prescribed for smokers or patients with certain lung diseases.
If you would like to learn more about Exubera, call 610-402-CARE, or speak to your physician about which type of insulin is best for you.
This page last updated 2/19/08 09:48 PM
 |
|
 |